This suggests that knockdown of VRK1 may lead to an increased level of apoptosis in LUSC, and it has also been previously shown that VRK1 can promote apoptosis in breast cancer cells [22] and posttransplant cardiomyocytes [23]. Here, VRK1 is linked to breast cancer.